English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduIn a first, the study published in the journal Emerging Microbes and Infections demonstrated the team’s patented therapeutic candidate, an HIV-virus-like-particle (HLP), is 100 times more effective than other candidate HIV cure therapeutics for people living with chronic HIV on combined antiretroviral therapy (cART).
Tag: Hiv Aids
Pride Month: Penn Nursing Experts Available to Discuss LGBTQ+ Issues
Topics Include: Eidos LGBTQ+ Health Initiative, Policy, HIV/AIDS, Sex Communication, Mental Health, Disparities, PrEP, Workplace Inclusion Experts Available Via Virtual/Phone/Email Interviews The Eidos LGBTQ+ Health Initiative at the University of Pennsylvania School of Nursing cultivates and engages emerging and experienced…
State-level Earned Income Tax Credit linked to reduction in high-risk HIV behavior among single mothers
UCLA research finds that a refundable State-level Earned Income Tax Credit (SEITC) of 10% or above the Federal EITC was associated with a 21% relative risk reduction in reported behavior that could put single mothers at high risk for becoming infected with HIV during the previous year. Also, a 10 percentage-point increase in SEITC was linked to a 38% relative reduction in the same reported high-risk behavior the previous year.
Miller School Researcher Publishes Breakthrough Findings on Nanoparticle Delivery of HIV/AIDS Medications to Brain
A University of Miami Miller School of Medicine biochemistry researcher has found that a nanoparticle drug delivery system can reduce HIV/AIDS viral reservoirs in the brain that normally contribute to neurological problems.
Common HIV drugs increase a type of immunity in the gut
In this research, the investigators studied the effect of TDF/FTC in patients who were using the drug to prevent HIV, and in the absence of active HIV infection. The researchers observed patients over the past five years and also included data from two earlier studies.
State Laws Key to HIV Prevention Efforts
HIV prevention remains a public health priority in the United States. Pre-exposure prophylaxis (PrEP) is a drug regimen recommended for individuals who have engaged in behaviors that place them at elevated risk for HIV. When used consistently, daily oral PrEP has been shown to reduce HIV transmission by 99 percent. However, despite increases in PrEP awareness and uptake over the past several years, data show that four of five people who could benefit from PrEP did not access the medication in 2018.
Long-acting, Injectable Drug Could Strengthen Efforts to Prevent, Treat HIV
Scientists have developed an injectable drug that blocks HIV from entering cells. They say the new drug potentially offers long-lasting protection from the infection with fewer side effects.
NYU Langone Health Launches Multi-faceted Vaccine Center
Building on its illustrious landmark-achieving history in the field of immunology, NYU Langone Health announced today the launch of a Vaccine Center that combines basic research, clinical studies and public health outreach to prevent the spread of infectious diseases and other immunological disorders.
Twitter chat with HIV/AIDS experts from the Johns Hopkins School of Nursing, Nov. 26, to prepare for World AIDS Day
The Johns Hopkins School of Nursing @JHUNursing is hosting a Twitter Chat in advance of World AIDS Day featuring its practitioners, researchers, and experts in HIV care, prevention, and science. Tuesday, November 26, 4:00 pm, EST Join and ask questions…